Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury

Journal of Applied Physiology

Volumn 80, Issue 4, 1996, Pages 1156-1164

  Lewis, Jim F ^a,b   Goffin, John ^a   Yue, Paul ^a   McCaig, Lynda A ^a   Bjarneson, Dave ^a   Veldhuizen, Ruud A W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

acute respiratory distress syndrome; bovine lipid extract surfactant; exogenous surfactant therapy; pulmonary surfactant distribution; Survanta

Indexed keywords

LUNG SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG DISTRIBUTION; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS SURFACE TENSION; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; SHEEP; TISSUE DISTRIBUTION;

EID: 0029921041     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.80.4.1156     Document Type: Article

References (32)

1. Anzueto, A., R. Baughman, K. Guntupalli, E. DeMaria, K. Davis, J. Weg, W. Long, J. Horton, and E. Pattishall. An international, randomized, placebo-controlled trial evaluating the safety and efficacy of aerosolized surfactant in patients with sepsis-induced ARDS (Abstract). Am. J. Respir. Crit. Care Med. 149, Suppl. pt. 2: A567, 1994.
2. Berggren, P., B. Lachmann, T. Curstedt, G. Grossmann, and B. Robertson. Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Acta Anaesthesiol. Scand. 30: 321-328, 1986.
3. Bligh, E. G., and W. J. Dyer. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917, 1959.
4. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
5. Cockshutt, A. M., D. R. Absolom, and F. Possmayer. The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins. Biochim. Biophys. Acta 1085: 248-256, 1991.
6. Duck-Chong, C. G. A rapid sensitive method for determining phospholipid phosphorus involving digestion with magnesium nitrate. Lipids 14: 492-497, 1979.
7. Engstrom, P. C., B. A. Holm, and S. Matalon. Surfactant replacement attenuates the increase in alveolar permeability in hyperoxia. J. Appl. Physiol. 67: 688-693, 1989.
8. Enhorning, G. Pulsating bubble technique for evaluating pulmonary surfactant. J. Appl. Physiol. 43: 198-203, 1977.
9. Gregory, T. J., J. E. Gadek, J. E. Weiland, T. M. Hyers, C. Crim, L. D. Hudson, K. P. Steinberg, R. A. Maunder, R. G. Spragg, R. M. Smith, D. F. Tierney, B. Gipe, W. J. Longmore, and M. A. Moxley. Survanta supplementation in patients with acute respiratory distress syndrome (ARDS) (Abstract). Am. J. Respir. Crit. Care Med. 149, Suppl. pt. 2: A567, 1994.
10. Gregory, T. J., W. J. Longmore, M.A. Moxley, G.-Z. Cai, J. E. Gadek, J. E. Weiland, T. M. Hyers, C. Crim, L. D. Hudson, K. P. Steinberg, R. A. Maunder, R. G. Spragg, R. M. Smith, D. F. Tierney, and B. Gipe. Surfactant repletion following Survanta supplementation in patients with acute respiratory distress syndrome (ARDS) (Abstract). Am. J. Respir. Crit. Care Med. 149, Suppl. pt. 2: A124, 1994.
11. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler, R. J. Maunder, C. Crim, and T. M. Hyers. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88: 1976-1981, 1991.
12. Hallman, M., P. Maasilta, I. Sipila, and J. Tahvanainen. Composition and function of pulmonary surfactant in adult respiratory distress syndrome. Eur. Respir. J. 3, Suppl.: 104s-108s, 1989.
13. Ikegami, M., T. Ueda, D. Absolom, C. Baxter, E. Rider, and A. H. Jobe. Changes in exogenous surfactant in ventilated preterm lamb lungs. Am. Rev. Respir. Dis. 148: 837-844, 1993.
14. Ito, Y., J. Goffin, R. Veldhuizen, M. Joseph, D. Bjarneson, L. McCaig, L.-J. Yao, J. Marcou, and J. Lewis. Timing of exogenous surfactant administration in a rabbit model of acute lung injury. J. Appl. Physiol. 80:1357-1364, 1996.
15. Lachmann, B. Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome. Eur Respir. J. 3, Suppl.: 98s-103s, 1989.
16. Lewis, J., J. Dhillon, and T. Frewen. Exogenous surfactant therapy in pediatric patients with ARDS (Abstract). Am. J. Respir. Crit. Care Med. 149, Suppl. pt. 2: A125, 1994.
17. Lewis, J. F., M. Ikegami, and A. H. Jobe. Altered surfactant function and metabolism in rabbits with acute lung injury. J. Appl. Physiol. 69: 2303-2310, 1990.
18. Lewis, J. F., M. Ikegami, A. H. Jobe, and D. Absolom. Physiologic responses and distribution of aerosolized surfactant (Survanta) in a nonuniform pattern of lung injury. Am. Rev. Respir. Dis. 147: 1364-1370, 1993.
19. Lewis, J. F., and A. H. Jobe. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147: 218-233, 1993.
20. Lewis, J. F., and L. A. McCaig. Aerosolized versus instilled exogenous surfactant in a nonuniform pattern of lung injury. Am. Rev. Respir. Dis. 148: 1187-1193, 1993.
21. Lewis, J. F., B. Tabor, M. Ikegami, A. H. Jobe, M. Joseph, and D. Absolom. Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J. Appl. Physiol. 74: 1256-1264, 1993.
22. Magoon, M. W., J. R. Wright, A. Baritussio, M. C. Williams, J. Goerke, B. J. Benson, R. L. Hamilton, and J. A. Clements. Subfractionation of lung surfactant. Implications for metabolism and surface activity. Biochim. Biophys. Acta 750:18-31, 1983.
23. Matalon, S., B. A. Holm, and R. H. Notter. Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant. J. Appl. Physiol. 62: 756-761, 1987.
24. Nosaka, S., T. Sakai, M. Yonekura, and K. Yoshikawa. Surfactant for adults with respiratory failure (Letter). Lancet 336: 947-948, 1990.
25. Novick, R. J., R. A. W. Veldhuizen, F. Possmayer, J. Lee, D. Sandler, and J. F. Lewis. Exogenous surfactant therapy in thirty-eight hour lung graft preservation for transplantation. J Thorac. Cardiovasc. Surg. 108: 259-268, 1994.
26. Pison, U., E. Gono, T. Joka, and U. Obertacke. Phospholipid lung profile in adult respiratory distress syndrome - evidence for surfactant abnormality. Prog. Clin. Biol. Res. 236A: 517-523, 1987.
27. Spragg, R. G., N. Gilliard, P. Richman, R. M. Smith, R. D. Hite, D. Pappert, B. Robertson, T. Curstedt, and D. Strayer. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 105: 195-202, 1994.
28. Taeusch, H. W., K. M. Keough, M. Williams, R. Slavin, E. Steele, A. S. Lee, D. Phelps, N. Kariel, J. Floros, and M. E. Avery. Characterization of bovine surfactant for infants with respiratory distress syndrome. Pediatrics 77: 572-581, 1986.
29. Veldhuizen, R. A., J. Lee, D. Sandler, W. Hull, J. A. Whitsett, J. Lewis, F. Possmayer, and R. J. Novick. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am. Rev. Respir. Dis. 148: 208-215, 1993.
30. Veldhuizen, R. A. W., L. McCaig, T. Akino, and J. F. Lewis, Pulmonary surfactant subfractions in patients with acute respiratory distress syndrome (ARDS). Am. J. Respir. Crit. Care Med 152: 1867-1871, 1995.
31. Weg, J., H. Reines, R. Balk, R. Tharratt, P. Kearney, T. Killian, D. Scholten, D. Zaccardelli, J. Horton, and E. Paltishall. Safety and efficacy of an aerosolized surfactant (Exosurf) in human sepsis induced ARDS. Chest 100: 137S, 1991.
32. Yu, S., P. G. Harding, N. Smith, and F. Possmayer. Bovine pulmonary surfactant: chemical composition and physical properties. Lipids 18: 522-529, 1983.